Document:

Exhibit 10.2

 

STOCKHOLDER SUPPORT AGREEMENT

 

This Stockholder Support Agreement
(this “Agreement”) is made and entered into as of September 20, 2021, by and among G Squared Ascend I
Inc., a Cayman Islands exempted company (which shall domesticate as a Delaware corporation in connection with the consummation of the
transactions contemplated by the Business Combination Agreement (as defined below)) (“SPAC”), Transfix, Inc.,
a Delaware corporation (the “Company”) and the undersigned stockholders (each, a “Written Consent
Party” and, collectively, the “Written Consent Parties”) of the Company. Capitalized terms used
but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Business Combination Agreement.

 

RECITALS

 

WHEREAS, on September 20,
2021, SPAC, the Company, Horizon Merger Sub Inc., a Delaware corporation and a direct, wholly owned Subsidiary of SPAC (“Merger
Sub”), and Transfix Holdings, Inc., a Delaware corporation and a direct, wholly owned Subsidiary of the Company (“Holdings”),
entered into a Business Combination Agreement (the “Business Combination Agreement”), pursuant to which, among
other things, (a) SPAC will merge with and into Holdings (the “Initial Merger”), with Holdings surviving
the Initial Merger and becoming the sole owner of Merger Sub and (b) immediately after the Initial Merger Effective Time, Merger
Sub will merge with and into the Company (the “Acquisition Merger” and, together with the Initial Merger, the
 “Business Combination”), with the Company surviving the Acquisition Merger as a wholly owned subsidiary of Holdings;

 

WHEREAS, pursuant to the Business
Combination Agreement, immediately prior to the Acquisition Merger Effective Time, each share of Company Preferred Stock that is issued
and outstanding immediately prior to the Acquisition Merger Effective Time shall automatically convert into a number of shares of Company
Common Stock at the then-effective conversion rate as calculated pursuant to the Company’s Certificate of Incorporation;

 

WHEREAS, the Business Combination
constitutes a Liquidation Event (as defined in the Company’s Certificate of Incorporation);

 

WHEREAS, pursuant to their
terms, upon consummation of the Business Combination, each of the following agreements will automatically terminate without any further
action on the part of the parties thereto pursuant to their respective terms: (i) that certain Amended and Restated Investors’
Rights Agreement, dated March 19, 2020, by and among the Company and the parties named therein (the “Investors’
Rights Agreement”); (ii) that certain Amended and Restated Company Voting Agreement, dated as of March 19, 2021,
by and among the Company and the parties named therein (the “Company Voting Agreement”); and (iii) that
certain Amended and Restated First Refusal and Co-Sale Agreement, dated March 19, 2021, by and among the Company and the parties
named therein (the “First Refusal and Co-Sale Agreement” and, together with the Investors’ Rights Agreement
and the Company Voting Agreement, the “Financing Agreements”);

 

     

     

    

 

WHEREAS, each Written Consent
Party agrees to enter into this Agreement with respect to all Company Securities (as defined below) that such Written Consent Party now
or hereafter owns, beneficially (as defined in Rule 13d-3 under the Exchange Act) or of record;

 

WHEREAS, each Written Consent
Party is the beneficial and/or record owner of, and has the sole right to vote or direct the voting of, such number of shares of Company
Stock as are set forth on Schedule A attached hereto opposite the name of such Written Consent Party;

 

WHEREAS, each of SPAC, the
Company and each Written Consent Party has determined that it is in its best interests to enter into this Agreement;

 

WHEREAS, each Written Consent
Party understands and acknowledges that each of SPAC and the Company is entering into the Business Combination Agreement in reliance upon
such Written Consent Party’s execution and delivery of this Agreement; and

 

WHEREAS, following the date
hereof, SPAC and Holdings intend to file with the SEC a registration statement on Form S-4 in connection with the matters set forth
in Section 7.02(a) of the Business Combination Agreement (the “Registration Statement”).

 

NOW, THEREFORE, in consideration
of the foregoing and the respective representations, warranties, covenants and agreements set forth below and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, do hereby
agree as follows:

 

1.            Definitions.
When used in this Agreement, the following terms in all of their tenses, cases and correlative forms shall have the meanings assigned
to them in this Section 1 or elsewhere in this Agreement.

 

“Affiliate”
of a specified person means a Person who, directly or indirectly through one or more intermediaries, controls, is controlled by, or is
under common control with, such specified Person (provided that if a Written Consent Party is a venture capital, private equity
or angel fund, no portfolio company of such Written Consent Party will be deemed an Affiliate of such Written Consent Party; provided
further that neither the Company nor any Company Subsidiary will be deemed an Affiliate of any Written Consent Party).

 

“Company
Securities” means, collectively, any Company Stock, Company Options, Company RSU Awards, Company Warrants, any securities convertible
into or exchangeable for any of the foregoing, and any interest in or right to acquire any of the foregoing, whether now owned or hereafter
acquired by any Written Consent Party hereto.

 

“Expiration
Time” shall mean the earlier to occur of (a) the Acquisition Merger Effective Time, (b) such date as the Business
Combination Agreement shall be validly terminated in accordance with Article IX thereof and (c) the effective date of a written
agreement of the parties hereto terminating this Agreement.

 

“Person”
means an individual, corporation, partnership, limited partnership, limited liability company, syndicate, person (including a “person”
as defined in Section 13(d)(3) of the Exchange Act), trust, association or entity or government, political subdivision, agency
or instrumentality of a government.

 

     2

     

    

 

“Transfer”
shall mean any direct or indirect sale, assignment, encumbrance, pledge, hypothecation, disposition, loan or other transfer, or entry
into any agreement with respect to any sale, assignment, encumbrance, pledge, hypothecation, disposition, loan or other transfer, excluding
(a) entry into this Agreement and the Business Combination Agreement and the consummation of the transactions contemplated hereby
and thereby and (b) the exercise of any Company Options or Company Warrants or settlement of any Company RSU Awards, in each case
in accordance with their terms.

 

2.            Agreement
to Retain the Company Securities.

 

2.1            No
Transfer of Company Securities. Until the Expiration Time, each Written Consent Party agrees not to, other than as expressly required
by the Business Combination Agreement (including pursuant to the Conversion) (a) redeem or Transfer any Company Securities, (b) deposit
any Company Securities into a voting trust or enter into a voting agreement or any similar agreement, arrangement or understanding with
respect to Company Securities or grant any proxy (except as otherwise provided herein), consent or power of attorney with respect thereto
(other than pursuant to this Agreement) (it being understood that the fact that certain Company Securities already may be subject to the
Company Voting Agreement shall not be deemed a violation of this Section 2.1 or Section 3.1 below), (c) enter
into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any
Company Securities held by such Written Consent Party, or (d) agree to or publicly announce any intention to effect any transaction
specified in clauses (a), (b) or (c); provided, that any Written Consent Party may Transfer any such Company Securities
to any Affiliate of such Written Consent Party, or if such Written Consent Party is a natural person, to immediate family or a trust for
the benefit of immediate family for estate planning purposes, if, and only if, the transferee of such Company Securities evidences in
a writing reasonably satisfactory to each of SPAC and the Company such transferee’s agreement to be bound by and subject to the
terms and provisions hereof to the same effect as such Written Consent Party.

 

2.2            Additional
Company Securities. Until the Expiration Time, each Written Consent Party agrees that any Company Securities that (a) are issued
to such Written Consent Party after the date of this Agreement pursuant to any stock dividend, stock split, recapitalization, reclassification,
combination or exchange of Company Securities or otherwise, (b) such Written Consent Party purchases or otherwise hereinafter acquires
(including as a result of the exercise of any Company Option or Company Warrant or settlement of any Company RSU Award) or (c) with
respect to which such Written Consent Party otherwise acquires sole or shared voting power after the execution of this Agreement and prior
to the Expiration Time shall be subject to the terms and conditions of this Agreement to the same extent as if they were owned by such
Written Consent Party as of the date hereof.

 

2.3            Unpermitted
Transfers. Any Transfer or attempted Transfer of any Company Securities in violation of this Section 2 shall, to the fullest
extent permitted by applicable Law, be null and void ab initio.

 

     3

     

    

 

3.            Agreement
to Consent and Approve.

 

3.1            Hereafter
until the Expiration Time, each Written Consent Party agrees that, except as otherwise agreed in writing with each of SPAC and the Company:

 

(a)            as
soon as reasonably practicable after the Registration Statement is declared effective under the Securities Act and delivered or otherwise
made available to stockholders, and in any event within forty-eight (48) hours after the Registration Statement is declared effective,
such Written Consent Party shall execute and deliver a written consent, substantially in the form attached as Exhibit D to the Business
Combination Agreement (the “Stockholder Written Consent”), which consent shall approve the Business Combination
Agreement, the Mergers and the other Transactions. Following such execution and delivery, each Written Consent Party hereby agrees that
it will not revoke, withdraw or repudiate the Stockholder Written Consent. The Stockholder Written Consent shall be coupled with an interest
and, prior to the Expiration Time, shall be irrevocable;

 

(b)            to
exercise the drag-along rights set forth in Section 4.2 of the Company Voting Agreement; and

 

(c)            at
the Acquisition Closing of the Business Combination Agreement, certain of such Written Consent Parties shall execute and deliver the Registration
Rights Agreement, substantially in the form attached as Exhibit C to the Business Combination Agreement.

 

Hereafter until the Expiration
Time, and subject to Section 2 hereof, no Written Consent Party shall enter into any tender or voting agreement, or any similar
agreement, arrangement or understanding, or grant a proxy or power of attorney, with respect to the Company Securities that is inconsistent
with this Agreement or otherwise take any other action with respect to the Company Securities that would prevent, materially restrict,
materially limit or materially interfere with the performance of such Written Consent Party’s obligations hereunder or the consummation
of the transactions contemplated hereby.

 

3.2            Hereafter
until the Expiration Time, at any meeting of the stockholders of the Company, or at any postponement or adjournment thereof, called to
seek the affirmative vote of the holders of the outstanding shares of Company Stock to adopt the Business Combination Agreement, or approve
the Mergers and the other Transactions, in any action by written consent or in any other circumstances upon which a vote, consent or other
approval (including the Stockholder Written Consent) with respect to the Business Combination Agreement, the Mergers or the other Transactions
is sought or upon which a consent or other approval is required under the Company’s Certificate of Incorporation or the Financing
Agreements, each Written Consent Party shall vote (or cause to be voted) all shares of Company Stock currently or hereinafter owned by
such Written Consent Party in favor of the foregoing. Additionally, hereafter until the Acquisition Merger Expiration Time, at any meeting
of the stockholders of the Company, or at any postponement or adjournment thereof, each Written Consent Party shall vote (or cause to
be voted) all shares of Company Stock currently or hereinafter owned by such Written Consent Party against any action, agreement or transaction
(other than the Business Combination Agreement or the Transactions) or proposal that would result in a breach of any covenant, representation
or warranty or any other obligation or agreement of the Company under the Business Combination Agreement or that would reasonably be expected
to result in the failure of the Transactions from being consummated.

 

     4

     

    

 

3.3            Hereafter
until the Expiration Time, at any meeting of the stockholders of the Company or at any postponement or adjournment thereof or in any other
circumstances upon which a Written Consent Party’s vote, consent or other approval (including by written consent) is sought, such
Written Consent Party shall vote (or cause to be voted) all Company Securities (to the extent such Company Securities are then entitled
to vote thereon), currently or hereinafter owned by such Written Consent Party against and withhold consent with respect to any Alternative
Transaction (as defined below). No Written Consent Party shall commit or agree to take any action inconsistent with the foregoing that
would be effective prior to the Expiration Time.

 

4.            Additional
Agreements.

 

4.1            Litigation.
Each Written Consent Party agrees not to commence, join in, facilitate, assist or encourage, and agrees to take all actions necessary
to opt out of any class in any class action with respect to, any claim, derivative or otherwise, against SPAC, Merger Sub, the Company,
Holdings or any of their respective successors, directors or officers (a) challenging the validity of, or seeking to enjoin the operation
of, any provision of this Agreement or the Business Combination Agreement or (b) alleging a breach of any fiduciary duty of any Person
in connection with the evaluation, negotiation or entry into this Agreement or the Business Combination Agreement.

 

4.2            Waiver
of Certain Rights. Each Written Consent Party hereby waives any requirement for notice with respect to the Transactions under each
Financing Agreement.

 

4.3            Termination
of Side Letter Agreements. Each Written Consent Party hereby agrees and consents to the termination of any Side Letter Agreements
to which such Written Consent Party is party, effective as of the Acquisition Merger Effective Time without any further liability or obligation
to Holdings, the Company, the Company Subsidiaries or SPAC.

 

4.4            Consent
to Disclosure. Each Written Consent Party hereby consents to the publication and disclosure in the Registration Statement (and, as
and to the extent otherwise required by applicable securities laws or the SEC or any other securities authorities, any other documents
or communications provided by SPAC or the Company to any Governmental Authority or to securityholders of SPAC) of such Written Consent
Party’s identity and beneficial ownership of Company Securities and the nature of such Written Consent Party’s commitments,
arrangements and understandings under and relating to this Agreement and, if deemed appropriate by SPAC or the Company, a copy of this
Agreement. Each Written Consent Party will promptly provide any information reasonably requested by SPAC or the Company for any regulatory
application or filing made or approval sought in connection with the Transactions (including filings with the SEC).

 

     5

     

    

 

4.5            Confidentiality.
Until the Expiration Time, each Written Consent Party will and will cause its Affiliates to keep confidential and not disclose any non-public
information relating to SPAC or the Company or any of their respective subsidiaries, including the existence or terms of, or transactions
contemplated by, this Agreement, the Business Combination Agreement or the other Transaction Documents, except to the extent that such
information (i) was, is or becomes generally available to the public after the date hereof other than as a result of a disclosure
by such Written Consent Party in breach of this Section 4.5, (ii) is, was or becomes available to such Written Consent
Party on a non-confidential basis from a source other than SPAC or the Company; provided that, to the knowledge of such Written
Consent Party, such information is not subject to a legal, fiduciary or contractual obligation of confidentiality or secrecy to SPAC
or the Company, or (iii) is or was independently developed by such Written Consent Party after the date hereof without use of, or
reference to any non-public information of SPAC or the Company. Notwithstanding the foregoing, such information may be disclosed to the
extent required to be disclosed in a judicial or administrative proceeding, or otherwise required to be disclosed by applicable Law (including
complying with any oral or written questions, interrogatories, requests for information or documents, subpoena, civil investigative demand
or similar process to which such disclosing party is subject), provided that such Written Consent Party gives SPAC or the Company,
as applicable, prompt notice of such request(s) or requirement(s), to the extent practicable (and not prohibited by Law), so that
SPAC or the Company may seek, at its expense, an appropriate protective order or similar relief (and such Written Consent Party shall
reasonably cooperate with such efforts).

 

5.            Representations
and Warranties of the Written Consent Parties. Each Written Consent Party hereby represents and warrants, severally and not jointly,
to SPAC and the Company as follows:

 

5.1            Due
Authority. Such Written Consent Party has the full power and authority to execute and deliver this Agreement and perform its obligations
hereunder. If such Written Consent Party is an individual, the signature to this agreement is genuine and such Written Consent Party has
legal competence and capacity to execute the same. This Agreement has been duly and validly executed and delivered by such Written Consent
Party and, assuming due execution and delivery by the other parties hereto, constitutes a legal, valid and binding obligation of such
Written Consent Party, enforceable against such Written Consent Party in accordance with its terms, except as limited by applicable Remedies
Exceptions.

 

5.2            Ownership
of the Company Securities. As of the date hereof, such Written Consent Party is the owner of the Company Securities set forth opposite
such Written Consent Party’s name on Schedule A, free and clear of any and all Liens, options, rights of first refusal
and limitations on such Written Consent Party’s voting rights, other than transfer restrictions under applicable securities laws
or the certificate of incorporation or bylaws or any equivalent organizational documents of the Company, as applicable, and restrictions
set forth in the Financing Agreements. Such Written Consent Party has sole voting power (including the right to control such vote as contemplated
herein), power of disposition and power to issue instructions with respect to all Company Securities currently owned by such Written Consent
Party, and the power to agree to all of the matters applicable to such Written Consent Party set forth in this Agreement. As of the date
hereof, such Written Consent Party does not own any Company Securities other than the Company Securities set forth opposite such Written
Consent Party’s name on Schedule A. As of the date hereof, such Written Consent Party does not own any rights to purchase
or acquire any Company Securities, except for the Company Warrants, Company Options and Company RSU Awards set forth opposite such Written
Consent Party’s name on Schedule A.

 

     6

     

    

 

5.3            No
Conflict; Consents.

 

(a)            The
execution and delivery of this Agreement by such Written Consent Party does not, and the performance by such Written Consent Party of
the obligations under this Agreement and the compliance by such Written Consent Party with any provisions hereof do not and will not:
(i) conflict with or violate any Law applicable to such Written Consent Party, (ii) if such Written Consent Party is an entity,
conflict with or violate the certificate of incorporation or bylaws or any equivalent organizational documents of the Company or such
Written Consent Party, or (iii) result in any breach of, or constitute a default (or an event, which with notice or lapse of time
or both, would become a material default) under, or give to others any rights of termination, amendment, acceleration or cancellation
of, or result in the creation of a Lien on any of the Company Securities owned by such Written Consent Party pursuant to any note, bond,
mortgage, indenture, contract, agreement, lease, license, permit, franchise or other instrument or obligation to which such Written Consent
Party is a party or by which such Written Consent Party is bound, except, in the case of clauses (i) and (iii), as
would not reasonably be expected, individually or in the aggregate, to materially impair the ability of such Written Consent Party to
perform its obligations hereunder or to consummate the transactions contemplated hereby.

 

(b)            The
execution and delivery of this Agreement by such Written Consent Party does not, and the performance of this Agreement by such Written
Consent Party will not, require any consent, approval, authorization or permit of, or filing or notification to, or expiration of any
waiting period by any Governmental Authority or any other Person with respect to such Written Consent Party, other than those set forth
as conditions to closing in the Business Combination Agreement.

 

5.4            Absence
of Litigation. As of the date hereof, there is no Action pending against, or, to the knowledge of such Written Consent Party after
reasonable inquiry, threatened against such Written Consent Party that would reasonably be expected to materially impair the ability of
such Written Consent Party to perform its obligations hereunder or to consummate the transactions contemplated hereby.

 

5.5            Absence
of Other Voting Agreement. Such Written Consent Party has not: (i) entered into any voting agreement, voting trust or any similar
agreement, arrangement or understanding, with respect to any Company Securities owned by such Written Consent Party (other than as contemplated
by this Agreement and the Company Voting Agreement), (ii) granted any proxy, consent or power of attorney with respect to any Company
Securities owned by such Written Consent Party (other than as contemplated by this Agreement and the Company Voting Agreement) or (iii) entered
into any agreement, arrangement or understanding that would prohibit or prevent it from satisfying or would materially interfere with,
or is otherwise materially inconsistent with, its obligations pursuant to this Agreement.

 

5.6            Broker.
Except as described in Section 4.23 of the Business Combination Agreement, no broker, finder, investment banker or other Person is
entitled to any brokerage fee, finders’ fee, underwriting fee, deferred underwriting fee, commission or other similar payment in
connection with the Transactions based upon arrangements made by such Written Consent Party, for which the Company or any of its Affiliates
may become liable.

 

     7

     

    

 

5.7            Adequate
Information. Such Written Consent Party is a sophisticated stockholder and has adequate information concerning the business and financial
condition of SPAC and the Company to make an informed decision regarding this Agreement and the Transactions and has independently and
without reliance upon SPAC or the Company and based on such information as such Written Consent Party has deemed appropriate, made its
own analysis and decision to enter into this Agreement. Such Written Consent Party acknowledges that SPAC and the Company have not made
and do not make any representation or warranty, whether express or implied, of any kind or character except as expressly set forth in
this Agreement. Such Written Consent Party acknowledges that the agreements contained herein with respect to the Company Securities held
by such Written Consent Party are irrevocable.

 

6.            Fiduciary
Duties. The covenants and agreements set forth herein shall not prevent any designee of any Written Consent Party from serving on
the board of directors of the Company or from taking any action, subject to the provisions of the Business Combination Agreement, while
acting in such designee’s capacity as a director of the Company. Each Written Consent Party is entering into this Agreement solely
in its capacity as the owner of such Written Consent Party’s Company Securities.

 

7.            Termination.
This Agreement shall terminate and be of no further force or effect at the Expiration Time. Notwithstanding the foregoing sentence, this
Section 7 and Section 10 shall survive any termination of this Agreement. Upon termination of this Agreement,
none of the parties hereto shall have any further obligations or liabilities under this Agreement; provided, that nothing in this
Section 7 shall relieve any party hereto of liability for any willful material breach of this Agreement prior to its termination.

 

8.            No
Ownership Interest. Nothing contained in this Agreement shall be deemed to vest in SPAC any direct or indirect ownership or incidence
of ownership of or with respect to any Written Consent Party’s Company Securities. All rights, ownership and economic benefits of
and relating to each Written Consent Party’s Company Securities shall remain fully vested in and belong to such Written Consent
Party, and SPAC shall have no authority to direct any Written Consent Party in the voting or disposition of any of Company Securities
except as otherwise provided herein.

 

     8

     

    

 

9.            Exclusivity.

 

9.1            From
the date of this Agreement and ending on the earlier of the Acquisition Closing and the valid termination of the Business Combination
Agreement, no Written Consent Party shall, and each Written Consent Party shall cause their Representatives acting on its behalf not to,
directly or indirectly, (1) enter into, solicit, initiate, knowingly facilitate, knowingly encourage or continue any discussions
or negotiations with, or knowingly encourage any inquiries or proposals by, or participate in any negotiations with, or provide any information
to, or otherwise cooperate in any way with, any person or other entity or “group” within the meaning of Section 13(d) of
the Exchange Act, concerning any (x) sale of any material assets of the Company and the Company Subsidiaries, taken as a whole, (y) sale
of any equity securities of the Company and the Company Subsidiaries, taken as a whole, or (z) merger, joint venture, consolidation,
liquidation, dissolution or similar transaction involving the Company and its Subsidiaries, taken as a whole (each, an “Alternative
Transaction”), (2) amend or grant any waiver or release under any standstill or similar agreement to which such Written
Consent Party is a party with respect to any class of equity securities of the Company or any of the Company Subsidiaries in connection
with any proposal or offer that could reasonably be expected to lead to an Alternative Transaction, (3) approve, endorse or recommend,
or propose publicly to approve, endorse or recommend, any Alternative Transaction, (4) approve, endorse, recommend, execute or enter
into any agreement in principle, confidentiality agreement, letter of intent, memorandum of understanding, term sheet, acquisition agreement,
merger agreement, option agreement, joint venture agreement, partnership agreement or other arrangement relating to any Alternative Transaction
or any proposal or offer that could reasonably be expected to lead to an Alternative Transaction, (5) commence, continue, permit
or renew any due diligence investigation regarding any Alternative Transaction, or (6) resolve or agree to do any of the foregoing
or otherwise authorize or permit any of its controlled affiliates or Representatives to take any such action. Each Written Consent Party
shall, and shall cause its controlled affiliates and Representatives acting on its behalf to, immediately cease any and all existing discussions
or negotiations with any person conducted heretofore with respect to any Alternative Transaction. Each Written Consent Party also agrees
that it will promptly request that each Representative of any special purpose acquisition corporation or similar person that has prior
to the date hereof executed a confidentiality agreement to which such Written Consent Party is a party in connection with its consideration
of an Alternative Transaction to return or destroy all Confidential Information furnished to such person by or on behalf of it pursuant
to such agreement prior to the date hereof.

 

9.2            From
the date of this Agreement and ending on the earlier of the Acquisition Closing and the valid termination of the Business Combination
Agreement, each Written Consent Party shall notify the Company and SPAC promptly after receipt by such Written Consent Party or any of
their securityholders or Representatives of any inquiry or proposal with respect to an Alternative Transaction, any inquiry that would
reasonably be expected to lead to an Alternative Transaction or any request for information relating to the Company or any of the Company
Subsidiaries or for access to the business, properties, assets, personnel, books or records of the Company or any of the Company Subsidiaries
by any third party, in each case that is related to or that would reasonably be expected to lead to an Alternative Transaction. In such
notice, such Written Consent Party shall identify the third party making any such inquiry, proposal, indication or request with respect
to an Alternative Transaction and provide the details of the material terms and conditions of any such inquiry, proposal, indication or
request. Each Written Consent Party shall keep the Company and SPAC informed, on a reasonably current and prompt basis, of the status
and material terms of any such inquiry, proposal, indication or request with respect to an Alternative Transaction, including the material
terms and conditions thereof any material amendments or proposed amendments.

 

9.3            If
any Written Consent Party or any of their Representatives receives any inquiry or proposal with respect to an Alternative Transaction
at any time prior to the Acquisition Closing, then such Written Consent Party shall promptly notify such person in writing that such Written
Consent Party is subject to an exclusivity agreement with respect to the Alternative Transaction that prohibits them from considering
such inquiry or proposal. Without limiting the foregoing, the parties agree that any violation of the restrictions set forth in this Section 9
by a Written Consent Party or its Affiliates or Representatives shall be deemed to be a breach of this Section 9 by such Written
Consent Party.

 

     9

     

    

 

10.            Miscellaneous.

 

10.1         Severability.
In the event that any term, provision, covenant or restriction of this Agreement, or the application thereof, is held to be illegal, invalid
or unenforceable under any present or future Law: (a) such provision will be fully severable; (b) this Agreement will be construed
and enforced as if such illegal, invalid or unenforceable provision had never comprised a part hereof; (c) the remaining provisions
of this Agreement will remain in full force and effect and will not be affected by the illegal, invalid or unenforceable provision or
by its severance herefrom; and (d) in lieu of such illegal, invalid or unenforceable provision, there will be added automatically
as a part of this Agreement a legal, valid and enforceable provision as similar in terms of such illegal, invalid or unenforceable provision
as may be possible.

 

10.2         Non-survival
of Representations and Warranties. None of the representations, warranties, covenants or agreements in this Agreement or in any schedule,
instrument or other document delivered pursuant to this Agreement shall survive the Expiration Time. Notwithstanding the foregoing, this
Section 10.2 shall not limit any covenant or agreement contained in this Agreement that by its terms is to be performed in
whole or in part after the Acquisition Merger Effective Time or the termination of this Agreement.

 

10.3         Assignment.
No party hereto may assign, directly or indirectly, including by operation of Law, either this Agreement or any of its rights, interests
or obligations hereunder without the prior written approval of the other parties hereto, except with respect to a Transfer completed in
accordance with Section 2.1. Subject to the first sentence of this Section 10.3, this Agreement shall be binding
upon and shall inure to the benefit of the parties hereto and their respective successors and permitted assigns. Any assignment in violation
of this Section 10.3 shall be void.

 

10.4         Amendments
and Modifications. This Agreement may be amended by the parties hereto at any time by execution of an instrument in writing signed
on behalf of each of the parties hereto.

 

10.5         Specific
Performance. The parties hereto agree that irreparable damage would occur if any provision of this Agreement were not performed in
accordance with the terms hereof, and, accordingly, that the parties shall be entitled to an injunction or injunctions to prevent breaches
of this Agreement or to enforce specifically the performance of the terms and provisions hereof in the Court of Chancery of the State
of Delaware, County of Newcastle, or, if that court does not have jurisdiction, any court of the United States located in the State of
Delaware without proof of actual damages or otherwise, in addition to any other remedy to which they are entitled at Law or in equity
as expressly permitted in this Agreement. Each of the parties hereby further waives (1) any defense in any action for specific performance
that a remedy at Law would be adequate and (2) any requirement under any Law to post security or a bond as a prerequisite to obtaining
equitable relief.

 

     10

     

    

 

10.6         Notices.
All notices, consents and other communications hereunder shall be in writing and shall be deemed given if delivered personally or by a
nationally recognized courier service guaranteeing overnight delivery, or sent via email to the parties hereto at the following addresses,
and such communications, to be valid, must be addressed as follows:

 

(i)            if
to SPAC or Merger Sub, to:

  

G Squared Ascend I Inc.

205 N Michigan Ave

Suite 3770

Chicago, IL 60601

Attention:
Ward Davis; Tom Hoban     

Email: ward@gsquared.com; tom@gsquared.com

 

with a copy (which shall not constitute notice) to:

 

Goodwin Procter LLP

620 Eighth Avenue

New York, NY 10018

Attention: Dan Espinoza, Ilan Nissan; Pavel Shaitanoff

Email: DEspinoza@goodwinlaw.com; INissan@goodwinlaw.com; PShaitanoff@goodwinlaw.com

 

(ii)            if
to the Company or Holdings, to:

 

Transfix, Inc.

498 7th Avenue

New York, NY 10018

Attention: Nicholas Smolansky, General Counsel

Email: nicksmolansky@transfix.io

 

with a copy (which shall not constitute notice) to:

 

Latham & Watkins LLP

555 Eleventh Street NW, Suite 1000

Washington, D.C. 20007

Attention: Paul F. Sheridan

Email: paul.sheridan@lw.com

 

Latham & Watkins LLP

1271 Avenue of the Americas

New York, NY 10020

Attention: Justin Hamill

Email: justin.hamill@lw.com

 

(iii)          if
to a Written Consent Party, to the address for notice set forth opposite such Written Consent Party’s name on Schedule A
hereto,

 

with a copy (which shall not constitute notice) to:

 

Latham & Watkins LLP

555 Eleventh Street NW, Suite 1000

Washington, D.C. 20007

Attention: Paul F. Sheridan

Email: paul.sheridan@lw.com

 

     11

     

    

 

Latham & Watkins LLP

1271 Avenue of the Americas

New York, NY 10020

Attention: Justin Hamill

Email: justin.hamill@lw.com

 

Unless otherwise specified herein, such notices
or other communications will be deemed given (a) on the date established by the sender as having been delivered personally; (b) one
Business Day after being sent by a nationally recognized overnight courier guaranteeing overnight delivery; (c) upon transmission,
if sent by email (provided no “bounceback” or notice of non-delivery is received); or (d) on the fifth Business
Day after the date mailed, by certified or registered mail, return receipt requested, postage prepaid.

 

10.7         Governing
Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware applicable to contracts
executed in and to be performed in that State. All legal actions and proceedings arising out of or relating to this Agreement shall be
heard and determined exclusively in any Delaware Chancery Court; provided, that if jurisdiction is not then available in the Delaware
Chancery Court, then any such legal Action may be brought in any federal court located in the State of Delaware or any other Delaware
state court. The parties hereto hereby (a) irrevocably submit to the exclusive jurisdiction of the aforesaid courts for themselves
and with respect to their respective properties for the purpose of any Action arising out of or relating to this Agreement brought by
any party hereto, and (b) agree not to commence any Action relating thereto except in the courts described above in Delaware, other
than Actions in any court of competent jurisdiction to enforce any judgment, decree or award rendered by any such court in Delaware as
described herein. Each of the parties further agrees that notice as provided herein shall constitute sufficient service of process and
the parties further waive any argument that such service is insufficient. Each of the parties hereby irrevocably and unconditionally waives,
and agrees not to assert, by way of motion or as a defense, counterclaim or otherwise, in any Action arising out of or relating to this
Agreement or the transactions contemplated hereby, (a) any claim that it is not personally subject to the jurisdiction of the courts
in Delaware as described herein for any reason, (b) that it or its property is exempt or immune from jurisdiction of any such court
or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid
of execution of judgment, execution of judgment or otherwise) and (c) that (i) the Action in any such court is brought in an
inconvenient forum, (ii) the venue of such Action is improper or (iii) this Agreement, or the subject matter hereof, may not
be enforced in or by such courts.

 

10.8         WAIVER
OF JURY TRIAL. Each of the parties hereto hereby waives to the fullest extent permitted by
applicable Law any right it may have to a trial by jury with respect to any litigation directly or indirectly arising out of, under or
in connection with this Agreement or the Transactions CONTEMPLATED HEREBY. Each of the parties hereto (a) certifies that no representative,
agent or attorney of any other party has represented, expressly or otherwise, that such other party would not, in the event of litigation,
seek to enforce that foregoing waiver and (b) acknowledges that it and the otherS hereto have been induced to enter into this Agreement
and the Transactions CONTEMPLATED HEREBY, as applicable, by, among other things, the mutual waivers and certifications in this Section 10.8.

 

     12

     

    

 

10.9         Entire
Agreement; Third-Party Beneficiaries. This Agreement constitutes the entire agreement among the parties hereto with respect to
the subject matter hereof and supersedes all prior agreements and understandings, both written and oral, among the parties hereto with
respect to the subject matter hereof, and is not intended to confer upon any other Person other than the parties hereto any rights or
remedies.

 

10.10        Counterparts.
This Agreement and each other document executed in connection with the transactions contemplated hereby, and the consummation thereof,
may be executed in one or more counterparts, all of which shall be considered one and the same document and shall become effective when
one or more counterparts have been signed by each of the parties hereto and delivered to the other parties hereto, it being understood
that all parties hereto need not sign the same counterpart. Delivery by electronic transmission to counsel for the other party of a counterpart
executed by a party shall be deemed to meet the requirements of the previous sentence.

 

10.11       Effect
of Headings. The headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning
or interpretation of this Agreement.

 

10.12       Legal
Representation. Each of the parties hereto agrees that it has been represented by independent counsel of its choice during the negotiation
and execution of this Agreement and each party hereto and its counsel cooperated in the drafting and preparation of this Agreement and
the documents referred to herein and, therefore, waive the application of any Law, regulation, holding or rule of construction providing
that ambiguities in an agreement or other document will be construed against the party hereto drafting such agreement or document. Each
Written Consent Party acknowledges that Latham & Watkins LLP is acting as counsel to the Company in connection with the Business
Combination Agreement and the Transactions, and that such firm is not acting as counsel to any Written Consent Party.

 

10.13       Expenses.
Except as otherwise set forth in this Agreement, all fees and expenses incurred in connection with this Agreement and the transactions
contemplated hereby shall be paid by the party hereto incurring such expenses.

 

10.14      Further
Assurances. At the request of SPAC or the Company, in the case of any Written Consent Party, or at the reasonable request of the Written
Consent Parties, in the case of SPAC or the Company, and without further consideration, each party shall execute and deliver or cause
to be executed and delivered such additional documents and instruments and take such further action as may be reasonably necessary to
consummate the transactions contemplated by this Agreement.

 

     13

     

    

 

10.15       Waiver.
No failure or delay on the part of either party to exercise any power, right, privilege or remedy under this Agreement shall operate as
a waiver of such power, right, privilege or remedy; and no single or partial exercise of any such power, right, privilege or remedy shall
preclude any other or further exercise thereof or of any other power, right, privilege or remedy. Neither party shall be deemed to have
waived any claim available to such party arising out of this Agreement, or any power, right, privilege or remedy under this Agreement,
unless the waiver of such claim, power, right, privilege or remedy is expressly set forth in a written instrument duly executed and delivered
on behalf of such waiving party; and any such waiver shall not be applicable or have any effect except in the specific instance in which
it is given.

 

10.16       Several
Liability. The liability of any Written Consent Party hereunder is several (and not joint). Notwithstanding any other provision of
this Agreement, in no event will any Written Consent Party be liable for any other Written Consent Party’s breach of such other
Written Consent Party’s representations, warranties, covenants, or agreements contained in this Agreement.

 

10.17       No
Recourse. Notwithstanding anything to the contrary contained herein or otherwise,
but without limiting any provision in the Business Combination Agreement, this Agreement may only be enforced against, and any claims
or causes of action that may be based upon, arise out of or relate to this Agreement, or the negotiation, execution or performance of
this Agreement or the transactions contemplated hereby, may only be made against the entities and Persons that are expressly identified
as parties to this Agreement in their capacities as such and no former, current or future stockholders, equity holders, controlling persons,
directors, officers, employees, general or limited partners, members, managers, agents or affiliates of any party hereto, or any former,
current or future direct or indirect stockholder, equity holder, controlling person, director, officer, employee, general or limited partner,
member, manager, agent or affiliate of any of the foregoing (each, a “Non-Recourse Party”) shall have any liability
for any obligations or liabilities of the parties to this Agreement or for any claim (whether in tort, contract or otherwise) based on,
in respect of, or by reason of, the transactions contemplated hereby or in respect of any oral representations made or alleged to be made
in connection herewith. Without limiting the rights of any party against the other parties hereto, in no event shall any party or any
of its affiliates seek to enforce this Agreement against, make any claims for breach of this Agreement against, or seek to recover monetary
damages from, any Non-Recourse Party.

 

[Signature pages follow.]

 

     14

     

    

 

In witness whereof, the parties
hereto have caused this Agreement to be executed as of the date first set forth above.

 

	 	G SQUARED ASCEND I INC.
	 	 
	 	By:	/s/ Ward Davis
	 	Name:	Ward Davis
	 	Title:	Chief Executive Officer
	 	 
	 	TRANSFIX, INC.
	 	 
	 	By:	/s/ Lily Shen
	 	Name:	Lily Shen
	 	Title:	Chief Executive Officer

 

Signature
Page to

Stockholder
Support Agreement

 

     

     

    

 

In witness whereof, the parties hereto have caused
this Agreement to be executed as of the date first set forth above.

 

	 	WRITTEN CONSENT PARTIES:
	 	 
	 	NEW ENTERPRISE ASSOCIATES 15, L.P.
	 	 
	 	By:     	NEA Partners 15, L.P., its general partner
	 	 
	 	By:     	NEA 15 GP, LLC, its general partner

 

 

		By:	/s/ Louis Citron

		Name:	Louis Citron

		Title:	Chief Administrative Officer

 

 

	 	NEW VENTURE 2016, LIMITED PARTNERSHIP

 

 

		By:	/s/ Louis Citron

		Name:	Louis Citron

		Title:	Chief Administrative Officer

 

Signature
Page to

Stockholder
Support Agreement

 

     

     

    

 

In witness whereof, the parties hereto have caused
this Agreement to be executed as of the date first set forth above.

 

	 	WRITTEN CONSENT PARTIES:
	 	 
		CANVAS VENTURE FUND, L.P.

 

	 	By:	Morgenthaler
Technology Members, LLC, its General Partner
	 	 	 
	 	 	 
		By:	/s/ Travis Boettner

		Name:	Travis Boettner

		Title:	Chief Financial Officer

 

Signature
Page to

Stockholder
Support Agreement

 

     

     

    

 

In witness whereof, the parties hereto have caused
this Agreement to be executed as of the date first set forth above.

  

	 	WRITTEN CONSENT PARTIES:
	 	 
	 	 
	 	/s/ Andrew McElroy
	 	Andrew McElroy
	 	 

  

Signature
Page to

Stockholder
Support Agreement

 

     

     

    

 

In witness whereof, the parties hereto have caused
this Agreement to be executed as of the date first set forth above.

 

 

	 	WRITTEN CONSENT PARTIES:
	 	 
	 	 
	 	/s/ Jonathan Salama
	 	Jonathan Salama

 

Signature
Page to

Stockholder
Support Agreement

 

     

     

    

 

In witness whereof, the parties hereto have caused
this Agreement to be executed as of the date first set forth above.

 

	 	WRITTEN CONSENT PARTIES:
	 	 
	 	SALAMA TRUST #1
	 	 
	 	 
	 	By:	/s/ Roger W. Plate
	 	Name:	Roger W. Plate
	 	Title:	Trustee
	 	 
	 	 
	 	SALAMA TRUST #2
	 	 
	 	 
	 	By:	/s/ Roger W. Plate
	 	Name:	Roger W. Plate
	 	Title:	Trustee
	 	 
	 	 
	 	SALAMA TRUST #3
	 	 
	 	 
	 	By:	/s/ Roger W. Plate
	 	Name:	Roger W. Plate
	 	Title:	Trustee

 

Signature
Page to

Stockholder
Support Agreement

 

     

     

    

 

Schedule A

 

	Written Consent

 Party	 	Address for Notice	 	Shares of

 Company

 Common

 Stock	 	 	Shares of

 Company

 Series A

 Preferred

 Stock	 	 	Shares of

 Company

 Series B

 Preferred

 Stock	 	 	Shares of

 Company

 Series C

 Preferred

 Stock	 	 	Shares of

 Company

 Series D

 Preferred

 Stock	 	 	Shares of

 Company

 Series E

 Preferred

 Stock	 	 	Shares of

 Company

 Series Seed

 Preferred

 Stock	 	 	Company

 Series D

 Warrants	 	 	Company

 Options	 	 	Company

 RSU

 Awards	 
	NEA Enterprise Associates 15, L.P.	 	1954 Greenspring Drive, Suite 600 Timonium, MD 21093	 	 	 	 	 	 	 	 	 	 	12,699,220	 	 	 	8,634,203	 	 	 	953,588	 	 	 	1,427,225	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	NEA Ventures 2016, Limited Partnership	 	1954 Greenspring Drive, Suite 600 Timonium, MD 21093	 	 	 	 	 	 	 	 	 	 	16,954	 	 	 	10,085	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Canvas Venture Fund, L.P.	 	3200 Alpine Road Portola Valley, CA 94028	 	 	 	 	 	 	10,411,244	 	 	 	4,269,030	 	 	 	576,286	 	 	 	23,839	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Andrew McElroy	 	498 7th Avenue
 New York, NY 10018	 	 	3,381,807	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	3,596,268	 	 	 	 	 
	Jonathan Salama	 	498 7th Avenue
 New York, NY 10018	 	 	1,069,307	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	3,596,268	 	 	 	 	 
	Salama Trust #1	 	498 7th Avenue
 New York, NY 10018	 	 	562,500	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Salama Trust #2	 	498 7th Avenue
 New York, NY 10018	 	 	875,000	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Salama Trust #3	 	498 7th Avenue
 New York, NY 10018	 	 	875,000Exhibit 10.3 

 

AMENDED AND RESTATED FORWARD PURCHASE AGREEMENT

 

This Amended and Restated
Forward Purchase Agreement (this “Agreement”) is entered into as of September 20, 2021, by and between G Squared
Ascend I Inc., a Cayman Islands exempted company (the “Company”), and G Squared Ascend Management I, LLC, a Cayman
Islands limited liability company (the “Purchaser”). Capitalized terms not defined in this Agreement shall have the
meaning giving such terms in the Business Combination Agreement (as defined below).

 

WHEREAS, the parties hereto
previously entered into that certain Forward Purchase Agreement, dated as of February 4, 2021 (the “Original FPA”),
and now desire to amend and restate the Original FPA in its entirety in accordance with the terms and conditions set forth herein;

 

WHEREAS, the Company was incorporated
for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination
with one or more businesses (a “Business Combination”);

 

WHEREAS, the Company filed
with the U.S. Securities and Exchange Commission (the “SEC”) a draft registration statement on Form S-1 (the “Registration
Statement”) for its initial public offering (“IPO”) of units (the “Public Units”) at a
price of $10.00 per Public Unit, each comprised of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A
Share(s)”), and one-fifth of one redeemable warrant, where each whole redeemable warrant is exercisable to purchase one Class A
Share at an exercise price of $11.50 per share (the “Warrant(s)”). Only whole Warrants are exercisable. A holder of
Warrants will not be able to exercise any fraction of a Warrant. The Company did not issue fractional Warrants other than as part of the
Public Units. If, upon the detachment of the Warrants from the Public Units or otherwise, a holder of Warrants would be entitled to receive
a fractional Warrant, the Company shall round down to the nearest whole number the number of Warrants to be issued to such holder;

 

WHEREAS, the Registration
Statement was declared effective on February 4, 2021;

 

WHEREAS, the Company intends
to consummate the Company’s initial Business Combination (the “Business Combination”), pursuant to that certain
Business Combination Agreement, dated as of September 20, 2021 (as may be amended, amended or restated or supplemented from time
to time, the “Business Combination Agreement”), by and among the Company, Horizon Merger Sub Inc., a Delaware corporation
and wholly owned direct subsidiary of the Company, Transfix, Inc., a Delaware corporation (“Transfix”), and Transfix
Holdings, Inc., a Delaware corporation and wholly owned direct subsidiary of Transfix; and

 

WHEREAS, the parties wish
to enter into this Agreement, pursuant to which immediately prior to the closing of the Business Combination (the “Business Combination
Closing”), the Company shall issue and sell, and the Purchaser shall purchase, on a private placement basis, the aggregate (i) number
of forward purchase securities (the “Forward Purchase Securities”), with each Forward Purchase Security consisting
of one Class A Share (the “Forward Purchase Share(s)”) and one-fifth of one Warrant (the “Forward Purchase
Warrant(s)”), and (ii) the aggregate number of Forward Purchase Warrants, in each case, determined pursuant to Section 1(a)(i) hereof
on the terms and conditions set forth herein;

 

NOW, THEREFORE, in consideration
of the premises, representations, warranties and the mutual covenants contained in this Agreement, and for other good and valuable consideration,
the receipt, sufficiency and adequacy of which are hereby acknowledged, the parties hereto agree as follows:

 

1. Sale and Purchase.

 

(a) Forward Purchase
Securities and Forward Purchase Warrants.

 

(i)            The
aggregate number of Forward Purchase Securities and Forward Purchase Warrants that the Company shall be required to issue and sell, and
the Purchaser shall be required to purchase, hereunder, and the aggregate purchase price to be paid for such Forward Purchase Securities
and Forward Purchase Warrants, shall be determined as follows:

 

A.            After
the Company’s final determination of the aggregate number of SPAC Class A Ordinary Shares redeemed pursuant to the Redemption
Rights (the “Redeemed Shares”) and the aggregate amount payable by the Company with respect to all Redeemed Shares
(the “Redemption Amount”), but in no event later than two (2) Business Days after the redemption date (as set
forth in the Registration Statement), the Company shall deliver a written notice to the Purchaser (such notice, the “Purchase
Notice”) specifying: (I) the Redeemed Shares and the Redemption Amount; (II) the aggregate number of public Class A
Shares purchased by Purchaser or any of its affiliates in transactions after the redemption date (as set forth in the Registration Statement)
and prior to the delivery of the Purchase Notice (the “Acquired Public Shares”) and the aggregate amount paid by Purchaser
and its affiliates with respect to all Acquired Public Shares (the “Acquired Public Share Purchase Price”); (III) the
anticipated date of the Business Combination Closing; (IV) the aggregate number of Forward Purchase Securities and Forward Purchase
Warrants and the aggregate Forward Purchase Price and Warrant Purchase Price, together with evidence of the calculations of such aggregate
amounts reasonably satisfactory to Transfix; and (V) instructions for wiring the Forward Purchase Price and the Warrant Purchase
Price.

 

 

    1

     

    

 

B.             Subject
to Section 1(a)(i)(D), the aggregate number of Forward Purchase Securities that the Company shall issue and sell, and the Purchaser
shall purchase, in each case, pursuant to this Agreement (the “Final Number of Forward Purchase Securities”), shall
equal: (I) the Committed Amount plus the Additional Amount; multiplied by (II) 0.1. The purchase price for each Forward
Purchase Security purchased and sold pursuant to this Section 1(a)(i)(B) shall equal $10.00.

 

C.             In
addition to the Final Number of Forward Purchase Securities, and subject to Section 1(a)(i)(D), the aggregate number of Forward Purchase
Warrants that the Company shall issue and sell, and the Purchaser shall purchase, in each case, pursuant to this Agreement, shall equal
a number of Forward Purchase Warrants equal to one-fifth of the Acquired Public Shares rounded down to the nearest whole Forward Purchase
Warrant (the “Final Number of Forward Purchase Warrants”). The purchase price for each Forward Purchase Warrant purchased
and sold pursuant to this Section 1(a)(i)(C) shall equal $0.0001 per whole Forward Purchase Warrant (the aggregate amount paid
by Purchaser with respect to all Forward Purchase Warrants purchased and sold pursuant to this Section 1(a)(i)(C), the “Forward
Purchase Warrant Price”).

 

D.            As
used in this Agreement, (I) “Committed Amount” means an amount, which shall in no event be less than zero
dollars ($0.00) or greater than fifty million dollars ($50,000,000), equal to fifty million dollars ($50,000,000) less the Acquired
Public Share Purchase Price; (II) “Additional Amount” means an amount, which shall in no event be less than zero
dollars ($0.00) or greater than fifty million dollars ($50,000,000), equal to the Redemption Amount less the amount, if any, by
which the Acquired Public Share Purchase Price exceeds fifty million dollars ($50,000,000); and (III) “Forward Purchase
Price” means the sum of the Committed Amount plus the Additional Amount. Notwithstanding anything in this Agreement to the contrary,
in no event will the sum of the Forward Purchase Price plus the Acquired Public Share Purchase Price equal an amount greater than
one hundred million dollars ($100,000,000).

 

(ii) Each Forward Purchase
Warrant will have the same terms as each Warrant sold as part of the Public Units in the IPO, and will be subject to the terms and conditions
of the Warrant Agreement, dated as of February 4, 2021, between the Company and Continental Stock Transfer & Trust Company,
as Warrant Agent (the “Warrant Agreement”). Each Forward Purchase Warrant will entitle the holder thereof to purchase
one Class A Share at a price of $11.50 per share, subject to adjustment as described in the Warrant Agreement, and only whole Forward
Purchase Warrants will be exercisable. The Forward Purchase Warrants will become exercisable thirty (30) days after the Business Combination
Closing, and will expire five years after the Business Combination Closing or earlier upon redemption or the liquidation of the Company,
as described in the Warrant Agreement.

 

    2

     

    

 

(iii) The closing of
the sale of the Final Number of Forward Purchase Securities and Final Number of Forward Purchase Warrants, if any (the “FPS Closing”),
shall be held on the same date and concurrently with the Business Combination Closing (such date being referred to as the “Closing
Date”). At least one (1) Business Day prior to the Closing Date, the Purchaser shall deliver to the Company the Forward
Purchase Price for the Final Number of Forward Purchase Securities and the Forward Purchase Warrant Price for the Final Number of Forward
Purchase Warrants, in each case, by wire transfer of U.S. dollars in immediately available funds to the account specified by the Company
in such notice to be held in escrow until the FPS Closing. Immediately prior to the FPS Closing on the Closing Date, (i) the Forward
Purchase Price and the Forward Purchase Warrant Price shall each be released to the Company from escrow automatically and without further
action by the Company or the Purchaser, and (ii) upon such release, the Company shall issue the Final Number of Forward Purchase
Securities and Final Number of Forward Purchase Warrants to the Purchaser in book-entry form, free and clear of any liens or other restrictions
whatsoever (other than those arising under state or federal securities laws, this Agreement, the Registration Rights Agreement (as defined
below), the Sponsor Support agreement or the Surviving Corporation Bylaws, as applicable), registered in the name of the Purchaser (or
its nominee(s)), or to a custodian designated by Purchaser (or its nominee(s)). In the event the Business Combination Closing does not
occur within five (5) Business Days of the scheduled Closing Date, the FPS Closing shall not occur and the Company shall promptly
(but not later than one (1) Business Day thereafter) return the Forward Purchase Price and the Forward Purchase Warrant Price to
the Purchaser. For purposes of this Agreement, “Business Day” means any day, other than a Saturday or a Sunday, that
is neither a legal holiday nor a day on which banking institutions are generally authorized or required by law or regulation to close
in the City of New York, New York.

 

(b) Delivery of Forward
Purchase Securities.

 

(i) The Company shall
register the Purchaser as the owner of the Final Number of Forward Purchase Securities and Final Number of Forward Purchase Warrants purchased
by the Purchaser hereunder (individually or collectively, the “Securities”) with the Company’s transfer agent
by book entry on or promptly after (but in no event more than two (2) Business Days after) the date of the FPS Closing.

 

(ii) Each register and
book entry for the Securities shall contain a notation, and each certificate (if any) evidencing the Securities shall be stamped or otherwise
imprinted with a legend, in substantially the following form:

 

“THE SECURITIES REPRESENTED HEREBY
HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION,
AND MAY NOT BE TRANSFERRED IN VIOLATION OF SUCH ACT AND LAWS. THE SALE, PLEDGE, HYPOTHECATION OR TRANSFER OF THE SECURITIES REPRESENTED
HEREBY ARE SUBJECT TO THE TERMS AND CONDITIONS OF A CERTAIN FORWARD PURCHASE AGREEMENT BY AND AMONG THE HOLDER AND THE COMPANY, COPIES
OF SUCH AGREEMENT MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY.”

 

(c) Legend Removal.
If the Securities are eligible to be sold without restriction under, and without the Company being in compliance with the current public
information requirements of, Rule 144 under the Securities Act of 1933, as amended (the “Securities Act”), then
at the Purchaser’s request, the Company will, at its sole expense, cause the Company’s transfer agent to remove the legend
set forth in Section 1(b)(ii). In connection therewith, if required by the Company’s transfer agent, the Company will
promptly cause an opinion of counsel to be delivered to and maintained with its transfer agent, together with any other authorizations,
certificates and directions required by the transfer agent that authorize and direct the transfer agent to transfer such Securities without
any such legend; provided, however, that the Company will not be required to deliver any such opinion, authorization or
certificate or direction if it reasonably believes that removal of the legend could result in or facilitate transfers of Securities in
violation of applicable law.

 

(d) Registration Rights.
The Purchaser shall have registration rights with respect to the Securities pursuant to that certain Amended and Restated Registration
Rights Agreement substantially in the form attached hereto as Exhibit A (the “Registration Rights Agreement”)
to be entered into by the Company, Purchaser and certain other parties at the Business Combination Closing.

 

(e) Antitrust Laws.
To the extent required under any Laws that are designed to prohibit, restrict or regulate actions having the purpose or effect of monopolization
or restraint of trade, including the HSR Act (“Antitrust Laws”), each of the Company and Purchaser agrees to promptly
make any required filing or application under Antitrust Laws, as applicable, and with respect to the HSR Act make any required filings
no later than fifteen (15) Business Days after the date of this Agreement. The Company and Purchaser hereto agree to supply as promptly
as reasonably practicable any additional information and documentary material that may be requested pursuant to Antitrust Laws and to
take all other actions necessary, proper or advisable to cause the expiration or termination of the applicable waiting periods or obtain
required approvals, as applicable, under Antitrust Laws as soon as practicable, including by requesting early termination of the waiting
period provided for under the HSR Act.

 

    3

     

    

 

2.
Representations and Warranties of the Purchaser. The Purchaser represents and warrants to the Company as follows, as of the
date hereof:

 

(a) Organization and
Power. The Purchaser is duly organized, validly existing, and in good standing under the laws of the jurisdiction of incorporation
or organization and has all requisite power and authority to carry on its business as presently conducted and as proposed to be conducted.

 

(b) Authorization.
The Purchaser has full power and authority to enter into this Agreement. This Agreement, when executed and delivered by the Purchaser,
will constitute the valid and legally binding obligation of the Purchaser, enforceable against the Purchaser in accordance with its terms,
except (a) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and any other laws
of general application affecting enforcement of creditors’ rights generally, (b) as limited by laws relating to the availability
of specific performance, injunctive relief or other equitable remedies, or (c) to the extent the indemnification provisions contained
in the Registration Rights Agreement may be limited by applicable federal or state securities laws.

 

(c) Governmental Consents
and Filings. No consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with,
any federal, state or local governmental authority is required on the part of the Purchaser in connection with the consummation of the
transactions contemplated by this Agreement.

 

(d) Compliance with
Other Instruments. The execution, delivery and performance by the Purchaser of this Agreement and the consummation by the Purchaser
of the transactions contemplated by this Agreement will not result in any violation or default (i) of any provisions of its organizational
documents, (ii) of any instrument, judgment, order, writ or decree to which it is a party or by which it is bound, (iii) under
any note, indenture or mortgage to which it is a party or by which it is bound, (iv) under any lease, agreement, contract or purchase
order to which it is a party or by which it is bound or (v) of any provision of federal or state statute, rule or regulation
applicable to the Purchaser, in each case (other than clause (i)), which would have a material adverse effect on the Purchaser or its
ability to consummate the transactions contemplated by this Agreement.

 

(e) Purchase Entirely
for Own Account. This Agreement is made with the Purchaser in reliance upon the Purchaser’s representation to the Company, which
by the Purchaser’s execution of this Agreement, the Purchaser hereby confirms, that the Securities to be acquired by the Purchaser
will be acquired for investment for the Purchaser’s own account, not as a nominee or agent, and not with a view to the resale or
distribution of any part thereof, and that the Purchaser has no present intention of selling, granting any participation in, or otherwise
distributing the same in violation of law. By executing this Agreement, the Purchaser further represents that the Purchaser does not presently
have any contract, undertaking, agreement or arrangement with any Person to sell, transfer or grant participations to such Person or to
any third Person, with respect to any of the Securities. For purposes of this Agreement, “Person” means an individual,
a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity
or any government or any department or agency thereof.

 

(f) Disclosure of Information.
The Purchaser has had an opportunity to discuss the Company’s business, management, financial affairs and the terms and conditions
of the offering of the Securities, as well as the terms of the Company’s IPO and the proposed Business Combination, with the Company’s
management.

 

(g) Restricted Securities.
The Purchaser understands that the offer and sale of the Securities to the Purchaser has not been, and will not be, registered under the
Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other
things, the bona fide nature of the investment intent and the accuracy of the Purchaser’s representations as expressed herein. The
Purchaser understands that the Securities are “restricted securities” under applicable U.S. federal and state securities laws
and that, pursuant to these laws, the Purchaser must hold the Securities indefinitely unless they are registered with the SEC and qualified
by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser acknowledges that
the Company has no obligation to register or qualify the Securities, or any Class A Shares into which the Securities may be converted
into or exercised for, for resale, except pursuant to the Registration Rights Agreement. The Purchaser further acknowledges that if an
exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to,
the time and manner of sale, the holding period for the Securities, and on requirements relating to the Company which are outside of the
Purchaser’s control, and which the Company is under no obligation and may not be able to satisfy. The Purchaser acknowledges that
the Registration Statement was declared effective on February 4, 2021. The Purchaser understands that the offering of the Securities
is not, and is not intended to be, part of the IPO, and that the Purchaser will not be able to rely on the protection of Section 11
of the Securities Act with respect to such Securities.

 

    4

     

    

 

(h) No Public Market.
The Purchaser understands that no public market now exists for the Securities, and that the Company has made no assurances that a public
market will ever exist for the Securities.

 

(i) High Degree of Risk.
The Purchaser understands that its agreement to purchase the Securities involves a high degree of risk which could cause the Purchaser
to lose all or part of its investment.

 

(j) Accredited Investor.
The Purchaser is an “accredited investor” as defined in Rule 501(a) of Regulation D promulgated under the Securities
Act.

 

(k) No General Solicitation.
Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners has either directly or indirectly,
including, through a broker or finder (i) to its knowledge, engaged in any general solicitation, or (ii) published any advertisement
in connection with the offer and sale of the Securities.

 

(l) Non-Public Information.
The Purchaser acknowledges its obligations under applicable securities laws with respect to the treatment of material non-public information
relating to the Company.

 

(m) Adequacy of Financing.
The Purchaser has available to it sufficient funds to satisfy its obligations under this Agreement.

 

(n) Affiliation of Certain
FINRA Members. The Purchaser is neither a person associated nor affiliated with UBS Investment Bank or, to its actual knowledge, any
other member of the Financial Industry Regulatory Authority that participated as an underwriter in the IPO.

 

(o) No Other Representations
and Warranties; Non-Reliance. Except for the specific representations and warranties contained in this Section 2 and in
any certificate or agreement delivered pursuant hereto, none of the Purchaser nor any person acting on behalf of the Purchaser nor any
of the Purchaser’s affiliates (the “Purchaser Parties”) has made, makes or shall be deemed to make any other
express or implied representation or warranty with respect to the Purchaser and this offering, and the Purchaser Parties disclaim any
such representation or warranty. Except for the specific representations and warranties expressly made by the Company in Section 3
of this Agreement and in any certificate or agreement delivered pursuant hereto, the Purchaser Parties specifically disclaim that they
are relying upon any other representations or warranties that may have been made by the Company, any person on behalf of the Company or
any of the Company’s affiliates (collectively, the “Company Parties”).

 

3.
Representations and Warranties of the Company. The Company represents and warrants to the Purchaser as follows:

 

(a) Incorporation and
Corporate Power. The Company is duly incorporated and validly existing and in good standing as an exempted company under the laws
of the Cayman Islands and has all requisite corporate power and authority to carry on its business as presently conducted and as proposed
to be conducted. The Company has no subsidiaries.

 

    5

     

    

 

(b) Authorization.
All corporate action required to be taken by the Company’s Board of Directors and shareholders in order to authorize the Company
to enter into this Agreement, and to issue the Securities at the FPS Closing, and the securities issuable upon conversion or exercise
of the Securities, has been taken or will be taken prior to the FPS Closing, as applicable. All action on the part of the shareholders,
directors and officers of the Company necessary for the execution and delivery of this Agreement, the performance of all obligations of
the Company under this Agreement to be performed as of the FPS Closing, and the issuance and delivery of the Securities and the securities
issuable upon conversion or exercise of the Securities has been taken or will be taken prior to the FPS Closing. This Agreement, when
executed and delivered by the Company, shall constitute the valid and legally binding obligation of the Company, enforceable against the
Company in accordance with its terms except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent
conveyance, or other laws of general application relating to or affecting the enforcement of creditors’ rights generally, (ii) as
limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies, or (iii) to
the extent the indemnification provisions contained in the Registration Rights Agreement may be limited by applicable federal or state
securities laws.

 

(c) Valid Issuance of
Securities.

 

(i) The Securities, when
issued, sold and delivered in accordance with the terms and for the consideration set forth in this Agreement, and the Company’s
amended and restated memorandum and articles of association (the “Articles”), and the securities issuable upon conversion
of exercise of the Securities, when issued in accordance with the terms of the Securities and this Agreement, will be validly issued,
fully paid and nonassessable and free of all preemptive or similar rights, taxes, liens, encumbrances and charges with respect to the
issue thereof and restrictions on transfer other than restrictions on transfer specified under this Agreement, the Registration Rights
Agreement, the Sponsor Support Agreement, the Surviving Corporation Bylaws, applicable securities laws and liens or encumbrances created
by or imposed by the Purchaser. Assuming the accuracy of the representations of the Purchaser in this Agreement and subject to the filings
described in Section 3(d) below, the Securities and the securities issuable upon conversion of the Securities will be
issued in compliance with all applicable federal and state securities laws.

 

(ii) No “bad actor”
disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities Act (a “Disqualification Event”)
is applicable to the Company or, to the Company’s knowledge, any Company Covered Person (as defined below), except for a Disqualification
Event as to which Rule 506(d)(2)(ii–iv) or (d)(3), is applicable. “Company Covered Person” means, with respect
to the Company as an “issuer” for purposes of Rule 506 promulgated under the Securities Act, any Person listed in the
first paragraph of Rule 506(d)(1).

 

(d) Governmental Consents
and Filings. Assuming the accuracy of the representations and warranties made by the Purchaser in this Agreement, no consent, approval,
order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental
authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement,
except for filings pursuant to Regulation D of the Securities Act, and applicable state securities laws and pursuant to the Registration
Rights Agreement.

 

(e) Compliance with
Other Instruments. The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated
by this Agreement will not result in any violation or default (i) of any provisions of the Company’s Articles or its other
governing documents, (ii) of any instrument, judgment, order, writ or decree to which it is a party or by which it is bound, (iii) under
any note, indenture or mortgage to which it is a party or by which it is bound, (iv) under any lease, agreement, contract or purchase
order to which it is a party or by which it is bound or (v) of any provision of federal or state statute, rule or regulation
applicable to the Company, in each case (other than clause (i)) which would have a material adverse effect on the Company or its ability
to consummate the transactions contemplated by this Agreement.

 

(f) Operations.
As of the date hereof, the Company has not conducted, and prior to the Business Combination Closing the Company will not conduct, any
operations other than organizational activities and activities in connection with offerings of the Securities or the Public Units in the
IPO.

 

(g) Foreign Corrupt
Practices. Neither the Company, nor any director, officer, agent, employee or other Person acting on behalf of the Company has, in
the course of its actions for, or on behalf of, the Company (i) used any corporate funds for any unlawful contribution, gift, entertainment
or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any foreign or domestic
government official or employee from corporate funds; (iii) violated or is in violation of any provision of the U.S. Foreign Corrupt
Practices Act of 1977, as amended; or (iv) made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful
payment to any foreign or domestic government official or employee.

 

    6

     

    

 

(h) Compliance with
Anti-Money Laundering Laws. The operations of the Company are and have been conducted at all times in compliance with applicable financial
recordkeeping and reporting requirements and all other applicable U.S. and non-U.S. anti-money laundering laws and regulations, including,
but not limited to, those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the USA Patriot Act of 2001 and
the applicable money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or
similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Anti-Money
Laundering Laws”), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any
arbitrator involving the Company with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened.

 

(i) Absence of Litigation.
There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory
organization or body pending or, to the knowledge of the Company, threatened against or affecting the Company or any of the Company’s
officers or directors, whether of a civil or criminal nature or otherwise, in their capacities as such.

 

(j) No General Solicitation.
Neither the Company, nor any of its officers, directors, employees, agents or shareholders, has either directly or indirectly, including,
through a broker or finder (i) engaged in any general solicitation or (ii) published any advertisement in connection with the
offer and sale of the Securities.

 

(k) No Other Representations
and Warranties; Non-Reliance. Except for the specific representations and warranties contained in this Section 3 and in
any certificate or agreement delivered pursuant hereto, none of the Company Parties has made, makes or shall be deemed to make any other
express or implied representation or warranty with respect to the Company, this offering, the IPO or the Business Combination, and the
Company Parties disclaim any such representation or warranty. Except for the specific representations and warranties expressly made by
the Purchaser in Section 2 of this Agreement and in any certificate or agreement delivered pursuant hereto, the Company Parties
specifically disclaim that they are relying upon any other representations or warranties that may have been made by the Purchaser Parties.

 

4.
FPS Closing Conditions.

 

(a) The obligation of the
Purchaser to purchase the Securities at the FPS Closing under this Agreement shall be subject to the fulfillment, at or prior to the FPS
Closing, of each of the following conditions, any of which, to the extent permitted by applicable laws, may be waived by the Purchaser:

 

(i) The Business Combination
shall be consummated substantially concurrent with, and immediately following, the purchase of Securities;

 

(ii) The representations
and warranties of the Company set forth in Section 3 of this Agreement shall have been true and correct as of the date hereof
and shall be true and correct as of the FPS Closing, as applicable, with the same effect as though such representations and warranties
had been made on and as of such date (other than any such representation or warranty that is made by its terms as of a specified date,
which shall be true and correct as of such specified date), except where the failure to be so true and correct would not have a material
adverse effect on the Company or its ability to consummate the transactions contemplated by this Agreement;

 

(iii) The Company shall
have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by this Agreement
to be performed, satisfied or complied with by the Company at or prior to the FPS Closing; provided, that, for purposes of this
Section 4(a)(iii), a covenant, agreement or condition of the Company shall only be deemed to have not been performed if the
Company has materially breached such covenant, agreement or condition and failed to cure within five (5) days after written notice
of such breach has been delivered to the Company;

 

    7

     

    

 

(iv) No order shall have
been entered by or with any governmental, regulatory, or administrative authority or any court, tribunal, or judicial, or arbitral body,
and no other legal restraint or prohibition shall be in effect, preventing the purchase by the Purchaser from the Company of the Securities;
and

 

(b) The obligation of the
Company to sell the Securities at the FPS Closing under this Agreement shall be subject to the fulfillment, at or prior to the FPS Closing,
of each of the following conditions, any of which, to the extent permitted by applicable laws, may be waived by the Company:

 

(i) The Business Combination
shall be consummated substantially concurrent with, and immediately following, the purchase of Securities;

 

(ii) The representations
and warranties of the Purchaser set forth in Section 2 of this Agreement shall have been true and correct as of the date hereof
and shall be true and correct as of the FPS Closing, as applicable, with the same effect as though such representations and warranties
had been made on and as of such date (other than any such representation or warranty that is made by its terms as of a specified date,
which shall be true and correct as of such specified date), except where the failure to be so true and correct would not have a material
adverse effect on the Purchaser or its ability to consummate the transactions contemplated by this Agreement;

 

(iii) The Purchaser shall
have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by this Agreement
to be performed, satisfied or complied with by the Purchaser at or prior to the FPS Closing; provided, that, for purposes of this
Section 4(b)(iii), a covenant, agreement or condition of the Purchaser shall only be deemed to have not been performed if
the Purchaser has materially breached such covenant, agreement or condition and failed to cure within five (5) days after written
notice of such breach has been delivered to the Purchaser; and

 

(iv) No order shall have
been entered by or with any governmental, regulatory, or administrative authority or any court, tribunal, or judicial, or arbitral body,
and no other legal restraint or prohibition shall be in effect, preventing the purchase by the Purchaser from the Company of the Securities.

 

5.
Termination. This Agreement may be terminated at any time prior to the FPS Closing:

 

(a) by mutual written consent
of Transfix, the Company and the Purchaser; or

 

(b) automatically:

 

(i) upon the valid termination
of the Business Combination Agreement in accordance with its terms; or

 

(ii) if the Company becomes
subject to any voluntary or involuntary petition under the United States federal bankruptcy laws or any state insolvency law, in each
case which is not withdrawn within sixty (60) days after being filed, or a receiver, fiscal agent or similar officer is appointed by a
court for business or property of the Company, in each case which is not removed, withdrawn or terminated within sixty (60) days after
such appointment.

 

In the event of any termination
of this Agreement pursuant to this Section 5, the Purchase Price (and interest thereon, if any), if previously paid, and all
the Purchaser’s funds paid in connection herewith shall be promptly returned to the Purchaser, and thereafter this Agreement shall
forthwith become null and void and have no effect, without any liability on the part of the Purchaser or the Company and their respective
directors, officers, employees, partners, managers, members, or stockholders and all rights and obligations of each party shall cease;
provided, however, that nothing contained in this Section 5 shall relieve either party from liabilities or damages
arising out of any fraud or willful breach by such party of any of its representations, warranties, covenants or agreements contained
in this Agreement.

 

    8

     

    

 

6.
General Provisions.

 

(a) Notices. All
notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given upon
the earlier of actual receipt, or (a) personal delivery to the party to be notified, (b) when sent, if sent by electronic mail
or facsimile (if any) during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient’s
next Business Day, (c) five (5) Business Days after having been sent by registered or certified mail, return receipt requested,
postage prepaid, or (d) one (1) Business Day after deposit with a nationally recognized overnight courier, freight prepaid,
specifying next Business Day delivery, with written verification of receipt. All communications sent to the Company shall be sent to:

 

G Squared Ascend I Inc.

205 N Michigan Ave

Suite 3770

Chicago, IL 60601

Attn: Tom Hoban, Chief Financial Officer

 

with a copy to the Company’s counsel at:

 

Goodwin Procter LLP

100 Northern Avenue

Boston, Massachusetts 02210

Attn: Jocelyn M. Arel, Esq.

 

All communications to the Purchaser shall be sent
to the Purchaser’s address as set forth on the signature page hereof, or to such e-mail address, facsimile number (if any)
or address as subsequently modified by written notice given in accordance with this Section 6(a).

 

(b) No Finder’s
Fees. Other than fees (whether deferred or otherwise) payable to UBS Investment Bank, which shall be the responsibility of the Company,
each party represents that it neither is nor will be obligated for any finder’s fee or commission in connection with this transaction.
The Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature
of a finder’s or broker’s fee arising out of this transaction (and the costs and expenses of defending against such liability
or asserted liability) for which the Purchaser or any of its officers, employees or representatives is responsible. The Company agrees
to indemnify and hold harmless the Purchaser from any liability for any commission or compensation in the nature of a finder’s or
broker’s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability)
for which the Company or any of its officers, employees or representatives is responsible.

 

(c) Survival of Representations
and Warranties. All of the representations and warranties contained herein shall survive the FPS Closing.

 

(d) Entire Agreement.
This Agreement, together with any documents, instruments and writings that are delivered pursuant hereto or referenced herein, constitutes
the entire agreement and understanding of the parties hereto in respect of its subject matter and supersedes all prior understandings,
agreements, or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter
hereof or the transactions contemplated hereby. The Original FPA is hereby amended and restated in its entirety; provided, that if this
Agreement is terminated pursuant to Section 5(b)(i)(B), this Agreement shall be null and void and the terms of the Original FPA will
be reinstated.

 

(e) Successors.
All of the terms, agreements, covenants, representations, warranties, and conditions of this Agreement are binding upon, and inure to
the benefit of and are enforceable by, the parties hereto and their respective successors. Nothing in this Agreement, express or implied,
is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations
or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. Notwithstanding anything to the contrary
set forth in this Agreement, the Company and the Purchaser hereby acknowledge and agree that Transfix is an express third party beneficiary
of this Agreement. Each of the parties hereto acknowledge and agree that Transfix shall be entitled to seek and obtain equitable relief,
without proof of actual damages, including an injunction or injunctions or order for specific performance to prevent breaches of this
Agreement and to enforce specifically the terms and provisions of this Agreement to cause the Company to cause, or directly cause, the
Purchaser to fund the aggregate Forward Purchase Price and the Forward Purchase Warrant Price and cause the FPS Closing to occur if the
conditions in Section 4 have been satisfied or, to the extent permitted by applicable law, waived.

 

    9

     

    

 

(f) Assignments.
Except as otherwise specifically provided herein, no party hereto may assign either this Agreement or any of its rights, interests, or
obligations hereunder without the prior written consent of the other party. Notwithstanding the foregoing, the Purchaser may assign and
delegate all or a portion of its rights and, obligations to purchase the Securities to one or more other persons or entities upon the
consent of the Company (which consent shall not be unreasonably conditioned, withheld or delayed); provided, however, that no consent
of the Company shall be required if such assignment or delegation is to an affiliate of Purchaser; provided, further, that no such assignment
or delegation shall relieve Purchaser of its obligations hereunder.

 

(g) Counterparts.
This Agreement may be executed in two or more counterparts, each of which will be deemed an original but all of which together will constitute
one and the same instrument.

 

(h) Headings. The
section headings contained in this Agreement are inserted for convenience only and will not affect in any way the meaning or interpretation
of this Agreement.

 

(i) Governing Law.
This Agreement, the entire relationship of the parties hereto, and any dispute between the parties (whether grounded in contract, tort,
statute, law or equity) shall be governed by, construed in accordance with, and interpreted pursuant to the laws of the State of New York,
without giving effect to its choice of laws principles.

 

(j) Jurisdiction.
The parties (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of New York and to the jurisdiction
of the United States District Court for the Southern District of New York for the purpose of any suit, action or other proceeding arising
out of or based upon this Agreement, (b) agree not to commence any suit, action or other proceeding arising out of or based upon
this Agreement except in state courts of New York or the United States District Court for the Southern District of New York, and (c) hereby
waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it
is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution,
that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper
or that this Agreement or the subject matter hereof may not be enforced in or by such court.

 

(k) Waiver of Jury Trial.
The parties hereto hereby waive any right to a jury trial in connection with any litigation pursuant to this Agreement and the transactions
contemplated hereby.

 

(l) Amendments.
This Agreement may not be amended, modified or waived as to any particular provision, except with the prior written consent of Transfix,
the Company and the Purchaser.

 

(m) Severability.
The provisions of this Agreement will be deemed severable and the invalidity or unenforceability of any provision will not affect the
validity or enforceability of the other provisions hereof; provided that if any provision of this Agreement, as applied to any
party hereto or to any circumstance, is adjudged by a governmental authority, arbitrator, or mediator not to be enforceable in accordance
with its terms, the parties hereto agree that the governmental authority, arbitrator, or mediator making such determination will have
the power to modify the provision in a manner consistent with its objectives such that it is enforceable, and/or to delete specific words
or phrases, and in its reduced form, such provision will then be enforceable and will be enforced.

 

(n) Expenses. The
Company will bear its own and the Purchaser’s costs and expenses incurred in connection with the preparation, execution and performance
of this Agreement and the consummation of the transactions contemplated hereby, including all fees and expenses of agents, representatives,
financial advisors, legal counsel and accountants; provided, however, that the Company shall not be required to pay any costs or expenses
of the Purchaser unless and until the Business Combination is consummated. The Company shall be responsible for the fees of its transfer
agent; stamp taxes and all of The Depository Trust Company’s fees associated with the issuance and resale of the Securities and
the securities issuable upon conversion or exercise of the Securities.

 

    10

     

    

 

(o) Construction.
The parties hereto have participated jointly in the negotiation and drafting of this Agreement. If an ambiguity or question of intent
or interpretation arises, this Agreement will be construed as if drafted jointly by the parties hereto and no presumption or burden of
proof will arise favoring or disfavoring any party hereto because of the authorship of any provision of this Agreement. Any reference
to any federal, state, local, or foreign law will be deemed also to refer to law as amended and all rules and regulations promulgated
thereunder, unless the context requires otherwise. The words “include,” “includes,” and “including”
will be deemed to be followed by “without limitation.” Pronouns in masculine, feminine, and neuter genders will be
construed to include any other gender, and words in the singular form will be construed to include the plural and vice versa, unless the
context otherwise requires. The words “this Agreement,” “herein,” “hereof,” “hereby,”
 “hereunder,” and words of similar import refer to this Agreement as a whole and not to any particular subdivision unless
expressly so limited. The parties hereto intend that each representation, warranty, and covenant contained herein will have independent
significance. If any party hereto has breached any representation, warranty, or covenant contained herein in any respect, the fact that
there exists another representation, warranty or covenant relating to the same subject matter (regardless of the relative levels of specificity)
which such party hereto has not breached will not detract from or mitigate the fact that such party hereto is in breach of the first representation,
warranty, or covenant.

 

(p) Waiver. No waiver
by any party hereto of any default, misrepresentation, or breach of warranty or covenant hereunder, whether intentional or not, may be
deemed to extend to any prior or subsequent default, misrepresentation, or breach of warranty or covenant hereunder or affect in any way
any rights arising because of any prior or subsequent occurrence.

 

(q) Confidentiality.
Except as may be required by law, regulation or applicable stock exchange listing requirements, unless and until the transactions contemplated
hereby and the terms hereof are publicly announced or otherwise publicly disclosed by the Company, the parties hereto shall keep confidential
and shall not publicly disclose the existence or terms of this Agreement.

 

[Signature Page Follows]

 

    11

     

    

 

IN
WITNESS WHEREOF, the undersigned have executed this Agreement to be effective as of the date first set forth above.

 

	 	PURCHASER:
	 	G Squared Ascend Management I, LLC 
	 	 	 
	 	By:	/s/ Larry Aschebrook
	 	 	Name: Larry Aschebrook
	 	 	Title: Manager
	 	 	 
	 	COMPANY:
	 	G SQUARED ASCEND I INC.
	 	 	 
	 	By:	/s/ Ward Davis
	 	 	Name: Ward Davis
	 	 	Title: Chief Executive Officer

 

[Signature Page to Forward Purchase Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}]]